ROME Therapeutics

Rome Therapeutics is developing novel therapies for cancer and autoimmune diseases by illuminating the role of the dark ...

a16z2020Active

What they do

Problem

Cancer and autoimmune diseases lack sufficiently effective therapies that address underlying genomic drivers beyond well-characterized genes.

Solution

The company develops therapeutics by investigating and targeting disease mechanisms within the “dark genome” to create new treatments.

Who it's for

Oncologists and immunologists treating patients in hospitals and specialty clinics.

Rosana Kapeller

David Ting

Benjamin Greenbaum